BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33052621)

  • 1. Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Steuer LV; Kondo AT; Cipolletta AN; Sakashita AM; Hamerschlak N; Kutner JM
    Transfusion; 2021 Jan; 61(1):159-166. PubMed ID: 33052621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience.
    Teofili L; Valentini CG; Bianchi M; Pellegrino C; Bellesi S; Chiusolo P; Laurenti L; Innocenti I; De Stefano V; Bacigalupo A
    Vox Sang; 2019 Oct; 114(7):762-768. PubMed ID: 31402471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey on preoperative autologous blood donation policy in bone marrow stem cell donors in Italy.
    Del Fante C; Masiello F; Vaglio S; Lombardini L; Coluzzi S; Rondinelli MB; Ciceri F; Pupella S; De Angelis V
    Blood Transfus; 2023 Jul; 21(4):337-344. PubMed ID: 36580031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
    Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
    Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suitability of autologous blood donation before bone marrow donation].
    Gouëzec H; Ferré N; Hervé F; Lapart C; Leberre C; Bernard M; Dauriac C; Nimubona S
    Transfus Clin Biol; 2015 Jun; 22(2):71-5. PubMed ID: 25958026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use.
    Leitner GC; Dettke M; List J; Worel N; Weigel G; Fischer MB
    Vox Sang; 2010 Apr; 98(3 Pt 1):e284-9. PubMed ID: 20059756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting old practices: More restricted indication of preoperative autologous blood donation in healthy bone marrow donors according to baseline hemoglobin levels.
    Gilli IO; Vigorito AC; Benites BD
    Transfus Apher Sci; 2019 Jun; 58(3):323-325. PubMed ID: 31036517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
    Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
    Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
    Shaw BE; Logan BR; Kiefer DM; Chitphakdithai P; Pedersen TL; Abdel-Azim H; Abidi MH; Akpek G; Diaz MA; Artz AS; Dandoy C; Gajewski JL; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Majhail NS; O'Donnell PV; Olsson RF; Savani BN; Schears RM; Stroncek DF; Switzer GE; Williams EP; Wingard JR; Wirk BM; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1830-8. PubMed ID: 26116089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
    Siddiq S; Pamphilon D; Brunskill S; Doree C; Hyde C; Stanworth S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006406. PubMed ID: 19160282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
    Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
    Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell donation.
    Chen SH; Wang TF; Yang KL
    Int J Hematol; 2013 Apr; 97(4):446-55. PubMed ID: 23420184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
    Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
    Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis.
    Farhadfar N; Murthy HS; Logan BR; Sees JA; Ayas M; Battiwalla M; Beitinjaneh AM; Chhabra S; Diaz MA; Engles K; Frangoul H; Ganguly S; Gergis U; Kamani NR; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Norkin M; O' Donnell PV; Olsson RF; Rossmann S; Savani BN; Schears R; Seo S; Solh MM; Spitzer T; Sugrue M; Yared JA; Linenberger M; Schwartz J; Pulsipher MA; Shah NN; Switzer GE; Confer DL; Shaw BE; Wingard JR
    Bone Marrow Transplant; 2020 Nov; 55(11):2121-2131. PubMed ID: 32355289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of hematopoietic stem cell donation in glucose 6 phosphate dehydrogenase-deficient donors.
    Pilo F; Baronciani D; Depau C; Targhetta C; Pani M; Manconi R; Fadda MG; Mamusa AM; Angelucci E
    Bone Marrow Transplant; 2013 Jan; 48(1):36-9. PubMed ID: 22732702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?
    Switzer GE; Goycoolea JM; Dew MA; Graeff EC; Hegland J
    Bone Marrow Transplant; 2001 May; 27(9):917-23. PubMed ID: 11436101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
    Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
    Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
    Kim H; Lee KH; Sohn SK; Kim I; Kim SH; Park Y; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Choi Y;
    Acta Haematol; 2020; 143(3):232-243. PubMed ID: 31390612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.